Genmab Logo

Genmab

GMAB | CO

Overview

Corporate Details

ISIN(s):
DK0010272202 (+2 more)
LEI:
529900MTJPDPE4MHJ122
Country:
Denmark
Address:
Carl Jacobsens Vej 30, 2500 Valby
Sector:
Health Care
Industry:
Biotechnology

Description

Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. Our headquarter is in Copenhagen, Denmark with sites in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan. We are the creators of three marketed products* and have a broad clinical and pre-clinical product pipeline. Genmab's technology consists of validated and proprietary next-generation antibody platforms - DuoBody® for generation of bispecific antibodies; HexaBody®, which creates effector-function enhanced antibodies; HexElect®, which combines two co-dependently acting HexaBody molecules to introduce selectivity while maximizing therapeutic potency; and DuoHexaBody®, which enhances the potential potency of bispecific antibodies through hexamerization.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-18 09:34
Share Issue/Capital Change
English 7.8 KB
2025-06-18 09:34
Share Issue/Capital Change
English 174.6 KB
2025-06-17 17:37
Directors' Dealings
English 204.0 KB
2025-06-17 17:37
Directors' Dealings
English 7.2 KB
2025-06-16 15:28
Transaction in Own Shares
English 25.5 KB
2025-06-16 15:28
Transaction in Own Shares
English 167.5 KB
2025-06-16 15:28
Transaction in Own Shares
English 117.3 KB
2025-06-10 13:22
Transaction in Own Shares
English 117.6 KB
2025-06-10 13:22
Transaction in Own Shares
English 167.4 KB
2025-06-10 13:22
Transaction in Own Shares
English 25.3 KB
2025-05-26 14:30
Transaction in Own Shares
English 167.7 KB
2025-05-26 14:30
Transaction in Own Shares
English 25.4 KB
2025-05-26 14:30
Transaction in Own Shares
English 776.6 KB
2025-05-20 18:01
Share Issue/Capital Change
English 180.1 KB
2025-05-20 18:01
Share Issue/Capital Change
English 7.8 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo 1NKEMIA Spain IKM
2cureX AB Logo 2cureX AB Sweden 2CUREX
4SC AG Logo 4SC AG Germany VSC
Abera Bioscience AB Logo Abera Bioscience AB Sweden ABERA
ABIONYX Pharma Logo ABIONYX Pharma France ABNX
Abliva Logo Abliva Sweden ABLI
AB Science Logo AB Science France AB
Acticor Biotech Logo Acticor Biotech France ALACT
Active Biotech Logo Active Biotech Sweden ACTI
AcuCort AB Logo AcuCort AB Sweden ACUC